Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
- PMID: 38015332
- PMCID: PMC10684837
- DOI: 10.1186/s40635-023-00566-8
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
Keywords: Acute kidney injury; Continuous kidney replacement therapy; Net fluid removal; Net ultrafiltration; Ultrafiltration rate.
Conflict of interest statement
RM, KK, and PMP filed an international patent application for the method of fluid removal described herein (Patent no. PCT/US2023/012204). RM received research grants from NIDDK and consulting fees from Baxter Inc., AM Pharma Inc., Bioporto Inc. and La Jolla Inc., unrelated to this study. KK received research grants NIDDK and from, Philips Research North America, and Google, a speaker honorarium from Nikkiso Critical Care Medical Supplies (Shanghai) Co., Ltd, and consulting fees to Mayo Clinic and from Baxter Inc.; PMP received consulting fees and advisory committee fees from Durect, Health-Span Dx, and Novartis; served on a Data and Safety Monitoring Board for Baxter; served as a member of an endpoint adjudication committee for GE Healthcare.
Similar articles
-
Correspondence regarding the article by Murugan et al. on "Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach".Intensive Care Med Exp. 2024 Feb 20;12(1):18. doi: 10.1186/s40635-023-00585-5. Intensive Care Med Exp. 2024. PMID: 38376740 Free PMC article. No abstract available.
-
Response Letter to: Correspondence regarding the article by Murugan et al on Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach.Intensive Care Med Exp. 2024 Feb 20;12(1):17. doi: 10.1186/s40635-023-00588-2. Intensive Care Med Exp. 2024. PMID: 38376597 Free PMC article. No abstract available.
-
Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study.Blood Purif. 2022;51(5):397-409. doi: 10.1159/000517281. Epub 2021 Jul 21. Blood Purif. 2022. PMID: 34289471
-
Ultrafiltration in critically ill patients treated with kidney replacement therapy.Nat Rev Nephrol. 2021 Apr;17(4):262-276. doi: 10.1038/s41581-020-00358-3. Epub 2020 Nov 11. Nat Rev Nephrol. 2021. PMID: 33177700 Review.
-
Kidney Replacement Therapy for Fluid Management.Crit Care Clin. 2021 Apr;37(2):433-452. doi: 10.1016/j.ccc.2020.11.006. Epub 2021 Feb 13. Crit Care Clin. 2021. PMID: 33752865 Review.
Cited by
-
Behind the scenes: Key lessons learned from the RELIEVE-AKI clinical trial.J Crit Care. 2024 Oct;83:154845. doi: 10.1016/j.jcrc.2024.154845. Epub 2024 Jun 15. J Crit Care. 2024. PMID: 38879964 Review.
-
Correspondence regarding the article by Murugan et al. on "Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach".Intensive Care Med Exp. 2024 Feb 20;12(1):18. doi: 10.1186/s40635-023-00585-5. Intensive Care Med Exp. 2024. PMID: 38376740 Free PMC article. No abstract available.
-
Protocolized fluid balance neutralization during continuous renal replacement therapy.Intensive Care Med. 2024 Dec;50(12):2141-2143. doi: 10.1007/s00134-024-07698-9. Epub 2024 Oct 31. Intensive Care Med. 2024. PMID: 39480517 No abstract available.
-
Response Letter to: Correspondence regarding the article by Murugan et al on Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach.Intensive Care Med Exp. 2024 Feb 20;12(1):17. doi: 10.1186/s40635-023-00588-2. Intensive Care Med Exp. 2024. PMID: 38376597 Free PMC article. No abstract available.
References
-
- (2012) Kidney Disease Improving Global Outcomes (KDIGO) Workgroup: Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2: 1–138
Grants and funding
LinkOut - more resources
Full Text Sources